Chronic allograft dysfunction (CAD) is a major problem in kidney transplant rejection. Using a mouse renal transplant model, Wang and co-workers show that inhibiting the innate immune system of the acceptor mouse, by knocking out the Toll-like receptor pathway, results in significantly healthier grafts. This research highlights the innate immune system as a possible focus for anti-CAD therapies.

Page 92